On January 29, 2020, Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP announced that they issued a statement commenting on Enzo Biochem, Inc’s January 28, 2020 press release announcing the postponement of its 2019 annual meeting of shareholders to February 25, 2020 and proposing the potential expansion of its Board of Directors to 7 seats from the current 5. Harbert Discovery stated that it has disappointed but not surprised that the Company has taken this desperate action, which is nothing more than a transparent attempt to undermine the will of the Company’s shareholders. Harbert Discovery stated that as the Company knew, at the time of the Company’s announcement, HDF held proxies totaling over a majority of the outstanding shares in support of HDF nominee Fabian Blank, and more than a majority of the shares of any recent quorum in support of HDF nominee Peter Clemens, IV. In addition, Harbert Discovery stated that the Company's attempt to claim some kind of credit for “no longer opposing” its nominees is ludicrous.